Human INAVA activation kit by CRISPRa
CAT#: GA110951
INAVA CRISPRa kit - CRISPR gene activation of human innate immunity activator
CNY 12255.00
CNY 1999.00
CNY 2700.00
CNY 7400.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | INAVA |
Locus ID | 55765 |
Kit Components | GA110951G1, INAVA gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA110951G2, INAVA gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA110951G3, INAVA gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_001142569, NM_018265, NM_001367290, NM_001367289 |
Synonyms | FLJ10901; MGC125608 |
Summary | Expressed in peripheral macrophages and intestinal myeloid-derived cells, is required for optimal PRR (pattern recognition receptor)-induced signaling, cytokine secretion, and bacterial clearance. Upon stimulation of a broad range of PRRs (pattern recognition receptor) such as NOD2 or TLR2, TLR3, TLR4, TLR5, TLR7 and TLR9, associates with YWHAQ/14-3-3T, which in turn leads to the recruitment and activation of MAP kinases and NF-kappa-B signaling complexes that amplifies PRR-induced downstream signals and cytokine secretion (PubMed:28436939). In the intestine, regulates adherens junction stability by regulating the degradation of CYTH1 and CYTH2, probably acting as substrate cofactor for SCF E3 ubiquitin-protein ligase complexes. Stabilizes adherens junctions by limiting CYTH1-dependent ARF6 activation (PubMed:29420262).[UniProtKB/Swiss-Prot Function] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN415863 | C1orf106 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |